Tickers

1. Composite Trajectory Verdict

For an asset-intensive transportation and logistics company, the income statement and cash flow statement carry the most weight for assessing operating performance, while the balance sheet reflects capital allocation and leverage management.

Composite Trajectory: Mixed

The annual series (2023–2025) shows a deteriorating revenue trend with operating margin compression that stabilized in 2025, while the quarterly series (YTD 2026 vs. YTD 2025) shows strong operating earnings improvement. Cash generation improved on an annual basis but YTD operating cash flow declined 10% despite higher earnings due to a large receivables build. The balance sheet shows equity erosion from share repurchases and minimal cash reserves, though debt was reduced significantly in H1 2026. The improving quarterly earnings and annual cash flow recovery are offset by annual revenue decline, persistent segment losses in ICS, FMS weakness, and working capital pressure on cash conversion.

2. Red Flags

• Cash and cash equivalents fell to $4.2 million at June 30, 2026 from $17.3 million at December 31, 2025 and $47.0 million at December 31, 2024 (10-Q 2026-06-30, Condensed Consolidated Balance Sheets; 10-K 2025-12-31, Consolidated Balance Sheets).
• YTD 2026 net cash provided by operating activities decreased 10% to $723 million despite a 31% increase in net earnings, driven by a $301 million increase in trade accounts receivable (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).
• Current ratio deteriorated to 0.83 at December 31, 2025 (current assets $1,604 million vs. current liabilities $1,935 million) before improving to 1.25 at June 30, 2026 after the current portion of long-term debt was reclassified to long-term (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
• Share repurchases of $923 million in FY 2025 and $178 million YTD 2026 occurred while cash balances remained minimal (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).
• FMS segment revenue declined 10% annually to $824 million and 6% YTD to $386 million, with operating income falling 55% annually to $27 million (10-K 2025-12-31, MD&A Segments; 10-Q 2026-06-30, Notes to Financial Statements - Business Segments).
• ICS segment remained loss-making at -$10 million operating loss for FY 2025 and -$3 million YTD 2026, though improved from -$56 million and -$6 million respectively (10-K 2025-12-31, MD&A Segments; 10-Q 2026-06-30, Notes to Financial Statements - Business Segments).
• Consolidated revenue has declined for three consecutive years: $12.83 billion (2023) → $12.09 billion (2024) → $12.00 billion (2025) (10-K 2025-12-31, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results show revenue declining for three straight years ($12.83B → $12.09B → $12.00B) with operating margin compressing from 7.7% (2023) to 6.9% (2024) before recovering to 7.2% (2025). Net earnings fell 21% in 2024 then rose 4.8% in 2025 to $598 million. Quarterly trends are stronger: YTD 2026 revenue grew 12% to $6.55 billion, operating income rose 24% to $467 million, and net earnings increased 31% to $323 million versus YTD 2025. All segments except FMS posted YTD revenue growth, with JBI up 12%, DCS up 6%, ICS up 35%, and JBT up 30%. ICS operating loss narrowed to -$3 million YTD 2026 from -$6 million YTD 2025, while JBT operating income declined to $1 million from $5 million.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow recovered to $1.68 billion in 2025 from $1.48 billion in 2024 (down from $1.74 billion in 2023). Capital expenditures declined sharply from $1.86 billion (2023) to $865 million (2024) to $731 million (2025), lifting annual free cash flow to approximately $947 million in 2025 from $618 million in 2024. However, YTD 2026 operating cash flow fell 10% to $723 million versus $806 million YTD 2025, entirely due to a $301 million increase in trade accounts receivable. YTD 2026 free cash flow was approximately $496 million ($723 million operating less $227 million capex) versus $344 million YTD 2025 ($806 million less $462 million), an improvement driven by lower capex. Net cash used in financing activities increased to $1.13 billion in 2025 and $591 million YTD 2026, primarily from share repurchases and dividend payments.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets were relatively stable at $7.93–$8.31 billion across periods. Total liabilities held near $4.30–$4.36 billion. Shareholders' equity declined 11% from $4.01 billion (Dec 2024) to $3.57 billion (Dec 2025) due to $923 million of treasury stock purchases, then recovered to $3.66 billion (Jun 2026) on retained earnings net of dividends and buybacks. Total debt decreased from $1.48 billion (Dec 2024) to $1.47 billion (Dec 2025) to $1.15 billion (Jun 2026) after the $700 million 3.875% senior notes matured in March 2026 and were replaced by a $350 million term loan and revolver borrowings. The current portion of long-term debt was $700 million at Dec 2025 and zero at Jun 2026, improving the current ratio from 0.83 to 1.25. Cash reserves remained minimal throughout ($47M → $17M → $4M). Claims accruals (current + long-term) rose from $626 million (Dec 2024) to $725 million (Dec 2025) to $810 million (Jun 2026).

6. Data Gaps

• Stand-alone Q3 and Q4 2025 quarterly income statements and cash flow statements (only FY 2025 annual and Q1/Q2 2025/2026 quarterly data provided).
• Full-year 2026 guidance or outlook figures (filings only contain historical results).
• Detailed breakdown of the $301 million YTD 2026 receivables increase by segment or customer type.
• Interest coverage ratio and debt-to-EBITDA metrics (not directly disclosed; would require calculation from available data).
• Segment-level capital expenditure breakdown for FY 2025 (only net capital expenditures by segment shown for YTD periods in 10-Q).
• Aging schedule for trade accounts receivable to assess collectibility of the YTD 2026 increase.